INTERACTIVE EVENT SUMMARY: Harnessing flow cytometry for high-throughput screening in immunotherapy development
Cell & Gene Therapy Insights 2025; 11(1), 1–5
10.18609/cgti.2025.001
Published: 20 January
Poster
Designing effective immunotherapies, such as CAR-T cell therapies, requires an in-depth understanding of immune dynamics. High-throughput screening (HTS) by cytometry can analyze and profile immune cells on a large scale. We assembled a panel of experts to discuss the use of HTS by cytometry to identify biomarkers, monitor cellular responses, and predict therapeutic efficacy. Here, we summarize some of the key takeaways from the discussion.